Abstract DP194: Cognitive Outcomes in Symptomatic Intracranial Stenosis: A Post-hoc SAMMPRIS Analysis of Stenting versus Aggressive Medical Management

Introduction: Intracranial atherosclerotic disease (ICAD) is a leading cause of stroke, yet the impact of treatment modality on cognitive function is not well established. In this post-hoc analysis of the SAMMPRIS trial, we compare cognitive outcomes in patients with symptomatic ICAD managed with percutaneous transluminal angiographic stenting to those treated with aggressive medical management. Methods: Using the SAMMPRIS trial sample of 451 patients, we further excluded to only include patients with symptomatic intracranial atherosclerotic stenosis with no periprocedural complications or stenting challenges. Cognitive outcomes between the stenting and aggressive medical management arms were assessed using the Montreal Cognitive Assessment (MoCA) at 30 days, 4 months, 12 months, and final follow-up. Multivariate linear and logistic regression models were used to adjust for baseline MoCA score, age, sex, and vascular risk factors. Results: Following exclusion, we analyzed 270 patients (stenting: 122, aggressive medical management: 152). The stenting group further exhibited significantly reduced odds of achieving MoCA ≥ 26 compared to the medical management group (OR 0.54, 95% CI 0.29 to 1.00, p=0.050), representing a 54% higher likelihood of reaching sub-normal cognitive outcome. Despite higher baseline cognitive function in the stenting group (median MoCA 26 vs 25, p=0.019), no significant difference was observed in continuous MoCA scores between patients receiving stenting and medical management (OR -0.63, 95% CI -1.60 to 0.34, p=0.205). Conclusion: Stenting was associated with decreased long-term cognitive outcomes relative to symptomatic ICAD treated with aggressive medical therapy. By raising concern about potential cognitive harm from interventional management, these findings highlight the importance of including cognitive outcomes as a factor in treatment selection.

Authors

Institutions

Publication Details

Journal
Stroke
Published
2026-01-29
DOI
https://doi.org/10.1161/str.57.suppl_1.dp194
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract DP194: Cognitive Outcomes in Symptomatic Intracranial Stenosis: A Post-hoc SAMMPRIS Analysis of Stenting versus Aggressive Medical Management

Ali Mansour, Rachel Mehendale, Karen Orjuela, James Ernest Siegler et al.
Stroke
Cerebrovascular and Carotid Artery Diseases
article

Abstract DP194: Cognitive Outcomes in Symptomatic Intracranial Stenosis: A Post-hoc SAMMPRIS Analysis of Stenting versus Aggressive Medical Management

Ali Mansour, Rachel Mehendale, Karen Orjuela, James Ernest Siegler, S Prabhakaran, Archit Baskaran, Elena Badillo Goicoechea, James R. Brorson, Taraf Jaro, Khalid Trad, Sonam Thind, Rami Morsi, Tareq Kass-Hout
article en

Abstract

Introduction: Intracranial atherosclerotic disease (ICAD) is a leading cause of stroke, yet the impact of treatment modality on cognitive function is not well established. In this post-hoc analysis of the SAMMPRIS trial, we compare cognitive outcomes in patients with symptomatic ICAD managed with percutaneous transluminal angiographic stenting to those treated with aggressive medical management. Methods: Using the SAMMPRIS trial sample of 451 patients, we further excluded to only include patients with symptomatic intracranial atherosclerotic stenosis with no periprocedural complications or stenting challenges. Cognitive outcomes between the stenting and aggressive medical management arms were assessed using the Montreal Cognitive Assessment (MoCA) at 30 days, 4 months, 12 months, and final follow-up. Multivariate linear and logistic regression models were used to adjust for baseline MoCA score, age, sex, and vascular risk factors. Results: Following exclusion, we analyzed 270 patients (stenting: 122, aggressive medical management: 152). The stenting group further exhibited significantly reduced odds of achieving MoCA ≥ 26 compared to the medical management group (OR 0.54, 95% CI 0.29 to 1.00, p=0.050), representing a 54% higher likelihood of reaching sub-normal cognitive outcome. Despite higher baseline cognitive function in the stenting group (median MoCA 26 vs 25, p=0.019), no significant difference was observed in continuous MoCA scores between patients receiving stenting and medical management (OR -0.63, 95% CI -1.60 to 0.34, p=0.205). Conclusion: Stenting was associated with decreased long-term cognitive outcomes relative to symptomatic ICAD treated with aggressive medical therapy. By raising concern about potential cognitive harm from interventional management, these findings highlight the importance of including cognitive outcomes as a factor in treatment selection.

StrokeVol. 57(Suppl_1)
University of Chicago (US)
Reduced inequalities
Openalex Percentile: Top 74%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.